HIGH-DOSE INACTIVATED INFLUENZA VACCINE IS ASSOCIATED WITH COST SAVINGS AND BETTER OUTCOMES COMPARED TO STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN SENIORS

被引:0
|
作者
Chit, A. [1 ]
Becker, D. L. [2 ]
Diazgranados, C. [1 ]
Maschio, M. [3 ]
Yau, E. [1 ]
Drummond, M. [4 ]
机构
[1] Sanofi Pasteur, Swiftwater, PA USA
[2] Optum, Burlington, ON, Canada
[3] OptumInsight, Burlington, ON, Canada
[4] Univ York, York YO10 5DD, N Yorkshire, England
关键词
D O I
10.1016/j.jval.2015.03.1399
中图分类号
F [经济];
学科分类号
02 ;
摘要
PIN75
引用
收藏
页码:A240 / A240
页数:1
相关论文
共 50 条
  • [21] Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients
    GiaQuinta, Sarah
    Michaels, Marian G.
    McCullers, Jonathan A.
    Wang, Li
    Fonnesbeck, Christopher
    O'Shea, Alice
    Green, Michael
    Halasa, Natasha B.
    PEDIATRIC TRANSPLANTATION, 2015, 19 (02) : 219 - 228
  • [23] Immunogenicity and Safety of High Dose vs. Standard Dose of inactivated Influenza Vaccine in Patients with rheumatoid Arthritis
    Christenn, Michaela
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (08): : 756 - 757
  • [24] Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial
    Chit, Ayman
    Becker, Debbie L.
    DiazGranados, Carlos A.
    Maschio, Michael
    Yau, Eddy
    Drummond, Michael
    LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1459 - 1466
  • [25] Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults? 60 years of age: Results from a phase III, randomized clinical trial
    Sanchez, Leilani
    Nakama, Takahiro
    Nagai, Hideaki
    Matsuoka, Osamu
    Inoue, Satoshi
    Inoue, Takahiro
    Shrestha, Anju
    Pandey, Aseem
    Chang, Lee-Jah
    De Bruijn, Iris
    VACCINE, 2023, 41 (15) : 2553 - 2561
  • [26] Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
    Samson, Sandrine I.
    Leventhal, Phillip S.
    Salamand, Camille
    Meng, Ya
    Seet, Bruce T.
    Landolfi, Victoria
    Greenberg, David
    Hollingsworth, Rosalind
    EXPERT REVIEW OF VACCINES, 2019, 18 (03) : 295 - 308
  • [27] Estimating Standard-Dose and High-Dose Fluzone Vaccine Efficacies for Influenza A Based on Hemagglutination Inhibition Titers
    Hammerton, Savannah M.
    Billings, W. Zane
    Hemme, Hayley
    Ross, Ted M.
    Shen, Ye
    Handel, Andreas
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [28] Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial
    Colmegna, Ines
    Useche, Mariana L.
    Rodriguez, Katherine
    McCormack, Deirdre
    Alfonso, Giuliana
    Patel, Aakash
    Ramanakumar, Agnihotram, V
    Rahme, Elham
    Bernatsky, Sasha
    Hudson, Marie
    Ward, Brian J.
    LANCET RHEUMATOLOGY, 2020, 2 (01): : E14 - E23
  • [29] Comparative effectiveness of high-dose versus standard-dose influenza vaccine among patients on chronic hemodialysis
    Butler, Anne M.
    Layton, J. Bradley
    Dharnidharka, Vikas R.
    Sahrmann, John M.
    Weber, David J.
    McGrath, Leah J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 239 - 239
  • [30] Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18
    Shinjoh, Masayoshi
    Sugaya, Norio
    Furuichi, Munehiro
    Araki, Eriko
    Maeda, Naonori
    Isshiki, Kyohei
    Ohnishi, Takuma
    Nakamura, Shoko
    Yamada, Go
    Narabayashi, Atsushi
    Nishida, Mitsuhiro
    Taguchi, Nobuhiko
    Nakata, Yuji
    Yoshida, Makoto
    Tsunematsu, Kenichiro
    Shibata, Meiwa
    Munenaga, Takeshi
    Hirano, Yasuhiro
    Ookawara, Ichiro
    Sekiguchi, Shinichiro
    Kobayashi, Yasuaki
    Yamaguchi, Yoshio
    Yoshida, Naoko
    Mitamura, Keiko
    Takahashi, Takao
    VACCINE, 2019, 37 (30) : 4047 - 4054